The role of ELABELA in targeted treatment of acute myeloid leukaemia
Acute myeloid leukaemia is a clonal stem cell disease. Various molecular targets are being sought in this disease which has a low chance of cure. However, it is desired that targeted treatments should have few side effects. We tried to understand whether the embryogenic peptide elabela, which has been closely associated with many pathways involved in cancer mechanism, is a peptide worth investigating in targeted treatment of acute myeloid leukaemia.
Authors
- Zeynep Tuğba Güven (ORCID: https://orcid.org/0000-0003-1600-9731)
- Didar Yanardağ Açık (ORCID: https://orcid.org/0000-0001-7282-0188)
Publication Details
- Journal
- Journal of Current Hematology & Oncology Research
- Published
- 2025-08-08
- DOI
- https://doi.org/10.51271/jchor-0065
- Primary Topic
- Apelin-related biomedical research
- Type
- article
- Field-Weighted Citation Impact
- 0.00